Search results
KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion
Zacks via Yahoo Finance· 1 month agoKORU Medical Systems, Inc. KRMD has made a strategic move in its pursuit of expanding its footprint...
5 Reasons Why You Should Add Halozyme (HALO) to Your Portfolio
Zacks via Yahoo Finance· 2 years agoHalozyme Therapeutics HALO licenses its novel drug delivery technology, ENHANZE, for the development...
Silo Pharma Stock Surges After Positive Study Results From Arthritis Study
Benzinga via Yahoo Finance· 1 year agoSilo Pharma Inc (NASDAQ: SILO) reported interim data from its dose optimization study of SPU-21...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023...
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Benzinga via Yahoo Finance· 1 year agoMorphoSys AG's (NASDAQ: MOR) partner Roche Holdings AG (OTC: RHHBY) announced results from the...
Sonnet Bio Reveals Pharmacokinetic, Pharmacodynamic Data In Early-Stage SON-1010 Trial
Benzinga via Yahoo Finance· 1 year agoSonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) announced that pharmacokinetic (PK) profile...
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance· 1 year agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing...
Pfizer's (PFE) Oral Diabetes Drug Aids in Weight Loss, Stock Up
Zacks via Yahoo Finance· 11 months agoData from a phase II study published in JAMA showed that Pfizer's (PFE) danuglipron reduces glycated...
FDA Recommends New Monkeypox Vaccine Strategy to Stretch Supply
Time via Yahoo News· 2 years agoA vial of the Jynneos monkeypox vaccine at a pop-up vaccination clinic operated by the Los Angeles...
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
GuruFocus.com via Yahoo Finance· 1 month agoQ4 Revenue: scPharmaceuticals Inc (NASDAQ:SCPH) reported $6.1 million in net FUROSCIX revenue, a 61%...